S4: #036: Mike Ryan on Creating Successful Businesses in Healthcare

In this episode we are joined by Mike Ryan. He is a widely recognized startup guru and has decades of experience across roles ranging from envelope-stuffer to CEO. In this episode, we talk about the role of resilience, creativity, collaboration and drive in creating successful companies. Mike Ryan has served as Vice President, President and CEO within some of the largest health systems in the US including Ascension Health, HealthTrust and HCA. He is a board member of several organizations and a trusted advisor and mentor for dozens of individuals and companies focusing on delivering health solutions. In fact, he has served as a founder, advisor, investor, board member or CEO of 60 companies including TransCare, Salorix, Proteolix, Calithera Biosciences, HealthOnline and healthcare.com. He has built an incredible network of relationships and is one of the most connected people on Linkedin with about 22,000 connections. He’s also been on the receiving end of life-saving healthcare, and he can tell us how that experience has shaped his perspective on life and business. What we cover in this episode: Mike’s journey in entrepreneurship as a family business The key characteristics of successful entrepreneurs The big ideas and big opportunities to transform healthcare The role of innovation labs in developing early stage health technologies The importance of having clinical input at the very outset of new companies and technologies The best place for startups to look for capital to fund their companies Some of the biggest failures in healthcare The innovation occurring to transform business models in healthcare Links and Resources Mentioned: Get a .health domain Mike Ryan on LinkedIn/ Mike Ryan on Twitter @MikeGordonRyan Peerwell Apexigen SherpaUS Healtheon Google Health Revolution Health Digital Health Events Join Digital Health Today Video: Startup Guru Mike Ryan: Funding StartUps Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.